초록 ▼

The present invention relates to compositions comprising terpenes which are particularly suitable for treating plant infections, to methods of making such compositions, and to methods of using them. The present invention also relates to compositions comprising terpenes and hollow glucan particles or

The present invention relates to compositions comprising terpenes which are particularly suitable for treating plant infections, to methods of making such compositions, and to methods of using them. The present invention also relates to compositions comprising terpenes and hollow glucan particles or cell wall particles and methods for preparing such compositions; such compositions increase terpene stability and activity and provide a suitable carrier for the terpenes. The invention also relates to methods of using such compositions in the medical, veterinary and agricultural fields. In particular, the terpenes disclosed are thymol, eugenol, geraniol, citral and L-carvone.

대표청구항 ▼

1. A method of treating or preventing a fungal infection in a plant caused by one or more of Colletotrichum graminicola and Botrytis cinerea, comprising: administering to the plant or to soil in proximity to the plant a therapeutically effective amount of a composition comprising hollow glucan parti

1. A method of treating or preventing a fungal infection in a plant caused by one or more of Colletotrichum graminicola and Botrytis cinerea, comprising: administering to the plant or to soil in proximity to the plant a therapeutically effective amount of a composition comprising hollow glucan particles or hollow cell wall particles encapsulating a terpene component, wherein the terpene component comprises a combination of thymol, eugenol, and geraniol in a weight ratio of 2:1:2,wherein the hollow glucan particles or hollow cell wall particles themselves have a lipid content of 10% w/w or greater. 2. The method of claim 1, wherein the infection comprises a fungal oomycete infection. 3. The method of claim 1, wherein the infection comprises a fungal oomycete infection, and wherein the fungal oomycete infection is caused by Botrytis cinerea. 4. The method of claim 1, wherein administering the composition to the plant or to soil in proximity to the plant occurs 21 days or less prior to harvesting the plant. 5. The method of claim 1, wherein administering the composition to the plant or to the soil in proximity to the plant occurs regularly. 6. The method of claim 1, wherein administering the composition to the plant or to soil in proximity to the plant comprises spraying. 7. The method of claim 1, wherein administering the composition to the plant or to soil in proximity to the plant comprises irrigation or a soil drench. 8. The method of claim 1, wherein the terpene component is in suspension or solution in water. 9. The method of claim 1, wherein the terpene component is in association with a surfactant. 10. The method of claim 9, wherein the surfactant is an organosilicone surfactant. 11. The method of claim 1, wherein the hollow glucan particles or cell wall particles are fungal cell walls. 12. The method of claim 1, wherein the hollow glucan particles or cell wall particles are yeast cell walls. 13. The method of claim 12, wherein the yeast cell walls are spray dried S. cerevisiae. 14. The method of claim 1, wherein the composition further comprises an additional active compound. 15. The method of claim 14, wherein the additional active compound comprises an antimicrobial agent, an enzyme, an anti-fungal agent, an anti-bacterial agent or an insecticidal agent.